Q&A with Andrea Pais, CEO of Novel Microdevices
Andrea Pais, a University of Florida graduate with a degree in Electrical Engineering, is CEO of Novel Microdevices, Inc., headquartered in Baltimore City, Maryland. She leads the development of groundbreaking, rapid, point-of-care molecular diagnostic solutions. With over 20 years in diagnostics and life sciences, Andrea has secured nearly $11 million in non-dilutive funding, including NIH RADx® Tech support, along with over $11 million in investor funding. Guided by her strategic vision, Novel Microdevices is dedicated to providing clinicians and patients with accessible, lab-quality diagnostic test results in minutes. Andrea is dedicated to transforming healthcare by making high-quality diagnostic testing widely accessible.
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com